SOLENTURE, LLC – Trademark Portfolio

Entity Type: 16

SOLENTURE, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include C-SUITE, SOLENTURE, and THE BENEFITS OF INNOVATIVE THINKING. The owner is based in PITTSBURGH, PA.

307 FOURTH AVENUE

SUITE 1300

PITTSBURGH, PA 15222

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SOLENTURE, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does SOLENTURE, LLC have?

SOLENTURE, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does SOLENTURE, LLC file in?

SOLENTURE, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.

What are SOLENTURE, LLC's most well-known trademarks?

SOLENTURE, LLC's registered trademark portfolio includes well-known marks such as C-SUITE, SOLENTURE, and THE BENEFITS OF INNOVATIVE THINKING. These are among 3 currently registered trademarks in the portfolio.

What is SOLENTURE, LLC's trademark registration success rate?

SOLENTURE, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.